Acquiring Company
Fortrea
Acquired Company
Worldwide Clinical Trials
DurhamDurhamBiotechnologyHealth CareMedicalBiotechnologyHealth CareMedicalPharmaceuticalDescription
Fortrea has signed an agreement to acquire Worldwide Clinical Trials' Early Phase Services division for approximately $45 million. This acquisition will enhance Fortrea’s clinical development capabilities, adding significant laboratory and clinical facilities. The transaction is aimed at strengthening their service offerings in North America. Completion is subject to regulatory approvals.
Quick answer
Fortrea is acquiring Worldwide Clinical Trials, announced September 3, 2026. Fortrea is based in Durham, North Carolina, United States.
- How much did Fortrea pay for Worldwide Clinical Trials?
- The deal value was not disclosed.
- What does Fortrea do?
- As a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, patient access solutions and other enabling services, Fortrea partners with emerging and large biopharma and medical..
- Where are Fortrea and Worldwide Clinical Trials based?
- Fortrea is based in Durham, North Carolina, United States. Worldwide Clinical Trials is based in Durham, North Carolina, United States.
- Who are the decision-makers at Fortrea?
- Fundz holds 2 contacts at Fortrea. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Petauri acquires Franklin Pharmaceutical Consulting (October 8, 2026)
- Lifecore Biomedical Announces Merger with Lifecore Inc. (September 27, 2026)
- Supernus to merge with Indivior Pharmaceuticals (August 3, 2026)
- Bedfont® acquires coVita™ to enhance US presence (October 13, 2026)
- Medtronic to exchange shares for MiniMed Group stock (October 7, 2026)
- Abacus Medicine acquires Delfarma in Poland (September 15, 2026)
Who to call at Fortrea, and when
When Fortrea changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Fortrea raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Fortrea, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Fortrea. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Fortrea makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Worldwide Clinical Trials?
Worldwide Clinical Trials was acquired by Fortrea, based in Durham. The deal was reported on September 3, 2026. Fortrea is publicly traded (FTRE) and operates in Biotechnology.
When did Fortrea acquire Worldwide Clinical Trials?
Fortrea's acquisition of Worldwide Clinical Trials was reported on September 3, 2026. Fortrea has signed an agreement to acquire Worldwide Clinical Trials' Early Phase Services division for approximately $45 million. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Worldwide Clinical Trials do?
Worldwide Clinical Trials (Worldwide) is a global full-service contract research organization (CRO). It is privately held, operating in Biotechnology, and is based in Durham.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.